DXCM Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 3790 min ago

@ $128.46

Wydano: 3 geg. 2024 @ 22:43

Zwrot: -0.07%

Poprzedni sygnał: geg. 2 - 20:59

Poprzedni sygnał: Sprzedaż

Zwrot: 2.01 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.62% compare to its pairs and should correct upwards.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally...

Stats
Dzisiejszy wolumen	1.78M
Średni wolumen	3.24M
Kapitalizacja rynkowa	51.05B
EPS	$0 ( 2024-04-25 )
Następna data zysków	( $0.390 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	83.36
ATR14	$2.31 (1.80%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Brown Michael Jon	Sell	629	Common Stock
2024-04-15	Dolan Matthew Vincent	Sell	1 990	Common Stock
2024-04-08	Sayer Kevin R	Sell	27 272	Common Stock
2024-04-08	Sayer Kevin R	Sell	22 361	Common Stock
2024-03-28	Brown Michael Jon	Sell	2 524	Common Stock

INSIDER POWER
-3.71
Last 99 transactions
Buy: 330 077 \| Sell: 350 609

Korelacja (AI algo v.1.1b): Undervalued: 0.62% $129.13 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: -0.25 (neutral)

Krótki: -0.82 (strong negative)

Signal:(40) Neutral

DexCom Inc Korelacja

10 Najbardziej pozytywne korelacje
CAPR	0.859
KRYS	0.848
STER	0.843
MRVI	0.837
DWAC	0.835
HCWB	0.834
ACMR	0.83
DWACU	0.822
SVBI	0.821
LZ	0.82

10 Najbardziej negatywne korelacje
RILYH	-0.83
NERV	-0.824
HNVR	-0.805
QTEK	-0.802

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DexCom Inc Korelacja - Waluta/Towar

-0.32
( neutral )

0.00
( neutral )

-0.22
( neutral )

-0.25
( neutral )

0.13
( neutral )

DexCom Inc Finanse

Annual	2023
Przychody:	$3.62B
Zysk brutto:	$2.29B (63.19 %)
EPS:	$1.400

FY	2023
Przychody:	$3.62B
Zysk brutto:	$2.29B (63.19 %)
EPS:	$1.400

FY	2022
Przychody:	$2.91B
Zysk brutto:	$1.88B (64.72 %)
EPS:	$0.880

FY	2021
Przychody:	$2.45B
Zysk brutto:	$1.68B (68.63 %)
EPS:	$0.400

Financial Reports:

No articles found.

DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.